Dissolution behavior of β-cyclodextrin molecular inclusion complexes of aceclofenac

Journal of Pharmacy and Bioallied Sciences

Volumn 3, Issue 3, 2011, Pages 417-425

  Dua, Kamal ^a   Pabreja, Kavita ^a   Ramana, M V ^b   Lather, Vinny ^c  

^a INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

^b VIT UNIVERSITY   (India)

^c UNIVERSITY OF MADEIRA   (Portugal)

Author keywords

CD; Aceclofenac; complexes; cyclodextrin; solubility

Indexed keywords

ACECLOFENAC; BETA CYCLODEXTRIN;

ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG MIXTURE; DRUG PURITY; DRUG RELEASE; DRUG SOLUBILITY; DRY WEIGHT; HYDROPHILICITY; IN VITRO STUDY; INFRARED SPECTROSCOPY; KINETICS; MOLECULAR MODEL; PARTICLE SIZE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; STOICHIOMETRY;

EID: 80052730345     PISSN: None     EISSN: 09757406     Source Type: Journal    
DOI: 10.4103/0975-7406.84457     Document Type: Article

References (32)

1. Hite M, Turner SF. Pharmaceutical Manufacturing and Packing Sourcer, Part 1. Oral Deliv of Poorly Soluble Drugs, Summer, 2003. Available from http://www.scolr.com/lit/PMPS-2003-1.pdf. [Last cited on 2011 Jan 11].
2. Goldberg AH, Gibaldi M, Kanig JL. Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures. I. Theoretical considerations and discussion of the literature. J Pharm Sci 1965;54:1145-8.
3. Goldberg AH, Gibaldi M, Kanig JL. Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures. II. Experimental Evaluation of Eutectic Mixture: Urea-Acetaminophen System. J Pharm Sci 1966;55:482-7.
4. Goldberg AH, Gibaldi M, Kanig JL, Mayersohn M. Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures. IV. Chloramphenicol-urea System. J Pharm Sci 1966;55:581-3.
5. Hörter D, Dressman JB. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv Drug Deliv Rev 2001;46:75-87.
6. Hancock BC, Zografi G. Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci 1997;86:1-12.
7. Loftsson T, Brewster ME. Pharmaceutical Applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci 1996;85:1017-25. (Pubitemid 26338912)
8. Astakhova AV, Demina NB. Modern drug technologies: Synthesis, characterization, and use of inclusion complexes between drugs and cyclodextrins (A Review). Pharm Chem J 2004;38 (2):105-8. (Pubitemid 38864880)
9. Florey K. Analytical Profiles of Drug Substances. Vol. 20. New York: Academic Press Inc.; 1991. p. 557-600.
10. Dua K, Sara UVS, Ramana MV. Acidic Solubilizing additives: Solubility promoters for aceclofenac cyclodextrin systems. Int J Pharma Excip 2007;4:101-5.
11. Dua K, Ramana MV, Sara UV, Himaja M, Agrawal A, Garg V. Investigation of enhancement of solubility of norfloxacin Cyclodextrin in presence of acidic solubilizing additives. Curr Drug Deliv 2007;4:21-5. (Pubitemid 46066411)
12. Patel HM, Suhagia BN, Shah SA, Rathod IS, Parmar VK. Preparation and characterization of etoricoxib-cyclodextrin complexes prepared by the kneading method. Acta Pharm 2007;57:351-9. (Pubitemid 47429179)
13. Higuchi T, Connors A. Phase-Solubility Techniques. In: Advances in Analytical Chemistry Instrumentation. Vol. 4. New York, NY: Wiley Interscience; 1965. p. 117-211.
14. Chauhan B, Shimpi S, Paradkar A. Preparation and characterization of etoricoxib solid dispersions using lipid carriers by spray drying technique. AAPS PharmSciTech 2005;6: E405-12.
15. Papageorgiou GZ, Bikiaris D, Karavas E, Politis S, Docoslis A, Park Y, et al. Effect of physical state and particle size distribution on dissolution enhancement of nimodipine/PEG solid dispersions prepared by melt mixing and solvent evaporation. AAPS J 2006;8: E623-31. (Pubitemid 44644163)
16. Bhargava S, Agrawal GP. Preparation and characterization of solid inclusion complex of cefpodoxime proxetil with beta-cyclodextrin. Curr Drug Deliv 2008;5:1-6. (Pubitemid 351225628)
17. Pop MM, Goubitz K, Borodi G, Bogdan M, De Ridder DJ, Peschar R, et al. Crystal structure of the inclusion complex of beta-cyclodextrin with mefenamic acid from high-resolution synchrotron powder-diffraction data in combination with molecular-mechanics calculations. Acta Crystallogr B 2002;58:1036-43. (Pubitemid 135688538)
18. Aree T, Chaichit N. A new crystal form of beta-cyclodextrin-ethanol inclusion complex: Channel-type structure without long guest molecules. CarbohyDr. Res 2003;338:1581-9. (Pubitemid 36829365)
19. Aigner Z, Hassan HB, Berkesi O, Kata M, Eros I. Thermoanalytical, FTIR and X-ray studies of gemfibrozil-cyclodextrin complexes. J Therm Anal Calorim 2005;81:267-72. (Pubitemid 41164950)
20. Babu MM, Prasad SD, Ramana Murthy KV. Development of new controlled release formulations of flurbiprofen: In vitro-in vivo correlation. Indian J Pharm Sci 2002;64:37-43.
21. Fernandes CM, Teresa VM, Veiga, FJ. Physicochemical characterization and in vitro dissolution behavior of nicardipine-cyclodextrin inclusion compounds. Eur J Pharm Sci 2002;15:79-88. (Pubitemid 34136971)
22. Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 2001;13:123-33. (Pubitemid 32288781)
23. Sethia S, Squilante E. Solid dispersions of carbamazepine in PVP K30 by conventional solvent evaporation and super critical methods. Int J Pharm 2004;272:1-10. (Pubitemid 38293005)
24. Martinez-Oharriz MC, Rodriguez-Espinosa C, Martín C, Goñi MM, Tros-Ilarduya MC, Sánchez M. Solid dispersions of diflunisal-PVP: Polymorphic and amorphous states of drug. Drug Dev Ind Pharm 2002;28:717-25. (Pubitemid 34809572)
25. Moffat AC, Osselton MD, Widdop B. Clarke's analysis of drugs and poisons in pharmaceuticals, body fluids and postmortem materials. 3rd ed, Vol. 2. Pharmaceutical Press, London; 2004. p. 570-1.
26. Soni T, Chirag Nagda, Tejal Gandhi and N. P. Chotai. Development of discriminating method for dissolution of aceclofenac marketed formulations. Dissolut Technol 2008;5:31-5.
27. Mutalik S, Naha A, Usha AN, Ranjith AK, Musmade P, Manoj K, et al. Preparation, in vitro, preclinical and clinical evaluations of once daily sustained release tablets of aceclofenac. Arch Pharm Res 2007;30:222-34.
28. Rawat S, Jain SK. Enhancement of intestinal absorption of few COX-2 inhibitors through interaction with cyclodextrin. Indian J Pharm Sci 2007;69:529-34. (Pubitemid 350099019)
29. Lin SY, Kao YH. Solid particulates of drug cyclodextrin inclusion complexes directly prepared by spray drying technique. Int J Pharm 1989;56:249-59.
30. Guyot M, F. Fawaz, J. Bildet, F. Bonini and A.M. Lagueny Physicochemical characterisation and dissolution of norfloxacin/cyclodextrin inclusion compounds and PEG solid dispersions. Int J Pharm 1995;123:53-63.
31. Shivakumar HN, Desai BG, Deshmukh G. Design and optimization of diclofenac sodium controlled release solid dispersions by response surface methodology. Indian J Pharm Sci 2008;70:22-30. (Pubitemid 351670564)
32. Goracinova K, L.J. Klisarova, A. Simov, E. Fredro-kumbaradzi and L. Petrusevska-tozi. Preparation, physical characterisation, mechanisms of drug/polymer interactions and stability studies of controlled release of solid dispersion granules containing weak base as active substance. Drug Deliv Ind. Pharm. 1996;22:255-62. (Pubitemid 26104641)